Three pathways of cell transformation of lymphoid cell: a slow, a rapid, and an accelerated
Jicun Wang-Michelitsch, Thomas M Michelitsch

TL;DR
This paper proposes three distinct pathways—slow, rapid, and accelerated—for lymphoid cell transformation leading to leukemia and lymphoma, based on different DNA change effects and cellular characteristics, explaining age-related disease occurrence.
Contribution
It introduces a novel framework categorizing lymphoid cell transformation pathways driven by specific DNA changes, linking them to age-related disease patterns.
Findings
Slow pathway involves accumulation of mild DNA changes, mainly in adults.
Rapid pathway driven by a single great-effect mutation can occur at any age.
Accelerated pathway involves multiple DNA changes, increasing with age.
Abstract
Lymphoid leukemia (LL) and lymphoma are neoplasms developed from lymphoid cells (LCs). To understand why different forms of LL/lymphoma occur at different ages, we analyzed the effects of different types of DNA changes on a LC and the cellular characteristics of LCs. Point DNA mutations (PDMs) and chromosome changes (CCs) are the two major types of DNA changes. CCs have three subtypes by their effects on a LC: great-effect CCs (GECCs), mild-effect CCs (MECCs), and intermediate-effect CCs (IECCs). PDMs and MECCs are mostly mild thus can accumulate in cells. Some of the PDMs/MECCs contribute to cell transformation. A GECC affects one or more genes and can alone drive cell transformation. An IECC affects one or more genes and participates in cell transformation. Due to cellular characteristics, a LC may have higher survivability from DNA changes and require obtaining fewer cancerous…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLymphoma Diagnosis and Treatment · Cancer Genomics and Diagnostics · Acute Lymphoblastic Leukemia research
